Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$VYNE Therapeutics (VYNE.US)$ Reuters· just
Vyne Therapeutics Reports Positive Top-Line Phase 1a Mad Data for Vyn202, Its Novel BD2-Selective Bet Inhibitor
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
459 Views
Comment
Sign in to post a comment